Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgia Colombo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|December 20, 2023
Correction to "An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline"Silvio Aprile, Giorgia Colombo, Marta Serafini, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
An Unexpected Deuterium-Induced Metabolic Switch in DoxophyllineSilvio Aprile, Giorgia Colombo, Marta Serafini, et al.
European Journal of Medicinal Chemistry|November 12, 2022
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reactionArash Foroutan, Marco Corazzari, Ambra A Grolla, et al.
Frontiers in Medicine|February 23, 2023
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel diseaseGiorgia Colombo, Gian Paolo Caviglia, Alberto Ravera, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-<i>a</i>]pyridines against the 1A FamilyLuca Quattrini, Edoardo Luigi Maria Gelardi, Giovanni Petrarolo, et al.
Cancers|January 22, 2021
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In VitroEdoardo L M Gelardi, Giorgia Colombo, Francesca Picarazzi, et al.
Journal of Medicinal Chemistry|February 19, 2026
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer TherapyUbaldina Galli, Marianna Moro, Federica Carolina Balestrero, et al.
European Journal of Medicinal Chemistry|August 11, 2019
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail groupCristina Travelli, Silvio Aprile, Daiana Mattoteia, et al.
Angiogenesis|December 5, 2024
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancerMarianna Moro, Federica Carolina Balestrero, Giorgia Colombo, et al.
Communications Biology|September 1, 2022
Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosisEdoardo L M Gelardi, Diego Caprioglio, Giorgia Colombo, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|December 20, 2023
Correction to "An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline"Silvio Aprile, Giorgia Colombo, Marta Serafini, et al.
ACS Medicinal Chemistry Letters|August 18, 2022
An Unexpected Deuterium-Induced Metabolic Switch in DoxophyllineSilvio Aprile, Giorgia Colombo, Marta Serafini, et al.
European Journal of Medicinal Chemistry|November 12, 2022
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reactionArash Foroutan, Marco Corazzari, Ambra A Grolla, et al.
Frontiers in Medicine|February 23, 2023
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel diseaseGiorgia Colombo, Gian Paolo Caviglia, Alberto Ravera, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-<i>a</i>]pyridines against the 1A FamilyLuca Quattrini, Edoardo Luigi Maria Gelardi, Giovanni Petrarolo, et al.
Cancers|January 22, 2021
A Selective Competitive Inhibitor of Aldehyde Dehydrogenase 1A3 Hinders Cancer Cell Growth, Invasiveness and Stemness In VitroEdoardo L M Gelardi, Giorgia Colombo, Francesca Picarazzi, et al.
Journal of Medicinal Chemistry|February 19, 2026
Development of PROTACs Targeting the Moonlighting Enzyme Nicotinamide Phosphoribosyltransferase (NAMPT) for Breast Cancer TherapyUbaldina Galli, Marianna Moro, Federica Carolina Balestrero, et al.
European Journal of Medicinal Chemistry|August 11, 2019
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail groupCristina Travelli, Silvio Aprile, Daiana Mattoteia, et al.
Angiogenesis|December 5, 2024
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) drives abnormal pericyte-rich vasculature in triple-negative breast cancerMarianna Moro, Federica Carolina Balestrero, Giorgia Colombo, et al.
Communications Biology|September 1, 2022
Curcumin-based-fluorescent probes targeting ALDH1A3 as a promising tool for glioblastoma precision surgery and early diagnosisEdoardo L M Gelardi, Diego Caprioglio, Giorgia Colombo, et al.
Pageof 3